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Abstract
Background: We describe the development of a novel matrix-assisted laser desorption ionization
time-of-flight (MALDI-TOF)-based single nucleotide polymorphism (SNP) scoring strategy, termed
Restriction Fragment Mass Polymorphism (RFMP) that is suitable for genotyping variations in a
simple, accurate, and high-throughput manner. The assay is based on polymerase chain reaction
(PCR) amplification and mass measurement of oligonucleotides containing a polymorphic base, to
which a typeIIS restriction endonuclease recognition was introduced by PCR amplification.
Enzymatic cleavage of the products leads to excision of oligonucleotide fragments representing
base variation of the polymorphic site whose masses were determined by MALDI-TOF MS.
Results: The assay represents an improvement over previous methods because it relies on the
direct mass determination of PCR products rather than on an indirect analysis, where a base-
extended or fluorescent report tag is interpreted. The RFMP strategy is simple and straightforward,
requiring one restriction digestion reaction following target amplification in a single vessel. With
this technology, genotypes are generated with a high call rate (99.6%) and high accuracy (99.8%) as
determined by independent sequencing.
Conclusion: The simplicity, accuracy and amenability to high-throughput screening analysis should
make the RFMP assay suitable for large-scale genotype association study as well as clinical
genotyping in laboratories.
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Background
Genetic differences contributed to phenotypic diversity of
humans or pathogens, including variation in disease sus-
ceptibility and drug response. The genotypic analysis to
identify the polymorphisms that differentiate one individ-
ual or strain from another has become increasingly
important as a prognostic measure of disease courses and
to enable choice of more efficacious therapeutic or pre-
ventive options based on individual genetic makeup. Due
to the complexity of many common, chronic diseases and
quantitative traits and the confounding effects of disease
heterogeneity, gene-gene interaction, and gene-environ-
ment interaction, a large number of the polymorphisms
must be surveyed in numerous individuals. These
progresses highlight the need for rapid, accurate, and effi-
cient methods that permit high throughput genotyping.
The most commonly used methods for genotype readout
are based either on fluorescence or mass spectrometry
(MS). Fluorescence readout is quite sensitive but often
relies on secondary reporter systems for detection [1,2]. In
contrast, MS readout has the advantage of directly detect-
ing fragments containing the original DNA sequence
information and thereby potentially reduces false positive
and false negative results [3]. Even though MS did not
contribute to the human genome-sequencing project, it
has become an essential tool in both protein and DNA
analyses in the past decade, as well as the key technology
in the emerging fields of proteomics and functional
genomics [4]. Developed in the late 1980s, MALDI-TOF
provided fast and accurate measurements of the molecu-
lar masses of short DNA sequences [5,6]. The ability to
measure directly the mass-to-charge (m/z) ratio of bio-
molecules with high accuracy made a wide range of bio-
analytical applications available to MS analysis [7-9].
Because of its speed, accuracy, and sensitivity, MALDI-
TOF MS has become a powerful tool for the efficient
sequencing of short DNA fragments as well as genotyping
of single nucleotide polymorphisms (SNPs) [10-16]. In
addition, the strength of MS lies in the fact that it uses an
intrinsic property of molecules, their masses. MS directly
assesses the nature of the PCR products, whereas other
technologies only indirectly measure PCR products, either
through hybridization or by sequencing reactions, which
use PCR products as templates. Procedures have been
widely used that use PCR products as templates to which
oligonucleotide primers are hybridized, base-extended
and then analyzed by mass spectrometry. These assays can
be useful, but they fail to employ one of key advantages of
mass spectrometry that the analysis of PCR products can
be direct. Genotyping by creating or abolishing recogni-
tion sites for restriction enzymes, similar to conventional
restriction fragment length polymorphism (RFLP) analy-
sis, has been used in combination with MALDI mass spec-
trometric detection [17]. Either naturally occurring
restriction sites were used or base changes were incorpo-
rated in one of the PCR primers to give a recognition site
with one of the alleles of the polymorphic site. However,
only a small number of polymorphisms will alter known
restriction sites, and the design of amplification primers
to create restriction sites in connection with one allele is
not straightforward in most cases, reducing the usefulness
of this approach to very special circumstances.
Here, we describe the development of a novel MALDI-
TOF MS-based SNP scoring strategy, termed RFMP, that is
suitable for genotyping SNPs in a simple, efficient, and
high-throughput manner. The assay is based on PCR
amplification and mass measurement of oligonucleotides
containing a polymorphic base, to which a typeIIS restric-
tion endonuclease recognition was introduced by PCR
amplification. We demonstrated fast, reliable genotyping
of five SNP markers in methylenetetrahydrofolate reduct-
ase (MTHFR) gene, known to be associated with hyperho-
mocysteinemia and cardiovascular diseases, using RFMP
assay and also assessed the potential for application to
determination of allele frequencies in DNA pools.
Results and Discussion
RFMP strategy for SNP scoring
The RFMP assay is based on mass spectrometric analysis of
small DNA fragments containing site of polymorphism,
as illustrated in Fig. 1. The first step requires PCR amplifi-
cation using primers flanking the altered bases. The for-
ward primer was designed to introduce a FokI site (an
isoschizomer of BstF5I) in the amplified product by sub-
stituting the restriction recognition sequence GGATG for
the ninth base upstream of the polymorphic nucleotide.
The backward primer was designed to make the resulting
amplicon as short as possible while both primers' Tm val-
ues matched with each other for better PCR yield. This
short inserted sequence in general is not expected to base
pair to the template strand, but rather loops out when the
primer is bound to the template. When the complemen-
tary strands are copied the inserted sequences are incorpo-
rated into the product. Both FokI and BstF5I are typeIIS
restriction enzymes that cleave DNA outside the recogni-
tion sequence. The FokI enzyme cleaves DNA 9 bases 3' to
the recognition site on one strand and 13 bases from the
recognition site on the other strand, leaving a four base
overhang protruding 5' end. BstF5I cleaves DNA 2 bases 3'
to the recognition site on one strand and immediately 3'
to the recognition site on the opposite strand, leaving a
two base overhang. Thus digestion of the resulting ampli-
fication product with FokI followed by BstF5I should
result in excision of a 7-mer fragment and a 13-mer frag-
ment. As summarized in Table 1, the 7-mer fragments
contain the polymorphic base at the last base of 3'-termi-
nal, and the 13-mer fragments contain the base comple-
mentary for the varied site and neighboring four bases.BMC Genomics 2008, 9:276 http://www.biomedcentral.com/1471-2164/9/276
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These fragments are then analyzed by mass spectrometry
to determine the base identity at the polymorphic site.
Inclusion of primer non-encoded 4 nucleotides in addi-
tion to the polymorphic site within the 13-mer allows
estimation for specific PCR amplification, leading to
improved precision in assay interpretation. From the
observation that reduction of inserted loop length gener-
ally improves assay performance, it is desirable to design
the modified primer so that inserted nucleotides are min-
imized by omitting the redundant sequence if the natural
sequence adjacent to the polymorphic site, either 5'-side
or the 3'-side, already contains a partial sequence for the
restriction endonuclease recognition. The optimal range
in the nucleotide length of 5'-arm and 3'-arm sequence
across the inserted loop in the engineered primer were
found within 16 to 19 and 6 to 8 bases, respectively. Opti-
mal gap for the inserted loop is found to be one base and
Tm of the primer pair is desirable to be higher than 65°C.
Software for designing the engineered primer and Tm-
matched backward primer was developed to integrate the
above mentioned empirical measures [see Additional file
1]. The embedding of sequence recognized by two typeIIS
restriction enzymes in one primer allows cleavage occurs
on both sides of the polymorphic site, releasing fragments
that falls in the range to be efficiently analyzed via mass
spectrometry without resort to modification of the oppo-
site primer, and universal flexibility in selection of target
SNP sites, independently of flanking sequences.
RFMP assay established in this study exploits differences
in the molecular masses of oligonucleotides comprising
the nucleotide variations. The assay is based on amplifica-
tion and mass detection of oligonucleotides excised from
typeIIS enzyme digestion using MALDI-TOF MS. Enzy-
matic cleavage of the products leads to excision of oligo-
nucleotide fragments representing base variation of the
polymorphic site whose mass was determined by MALDI-
TOF MS. This genotyping assay represents an improve-
ment over previous methods because it relies on the direct
mass determination of PCR products rather than on an
indirect analysis, where a fluorescent or radioactive report
tag is interpreted. Further, both DNA strands can be ana-
lyzed in parallel, and the specific target amplification can
be validated simultaneously with mass analysis, provid-
ing a level of internal confirmation not achievable by
other methods. The use of a typeIIS restriction enzyme
makes this assay independent of the fortuitous occurrence
of restriction sites, because these enzymes have cleavage
sites distal to their recognition sites. Recognition sites are
incorporated into the amplification primers, and short
fragments that contain the polymorphisms can be gener-
ated for mass spectrometric analysis. The RFMP strategy is
simple and straightforward, requiring one restriction
digestion reaction following target amplification in a sin-
gle vessel.
Assay performance and validation
Mass spectra were acquired on a linear MALDI-TOF MS
(Biflex IV; Bruker Daltonics) workstation equipped with a
337 nm nitrogen laser and a nominal ion flight path
length of 1.25 m as previously described with slight mod-
ification [15]. The samples were analyzed in a negative ion
mode by using a total acceleration voltage of 20 kV with
an 18.25-kV extraction voltage, laser attenuation of 55
and delayed extraction of long time delay. Typically, time-
of-flight data from 10 individual laser pulses were
recorded and averaged on a transient digitizer with time
base of 2 ns and delay of 24000 ns, after which the aver-
aged spectra were automatically converted to mass by
accompanying data processing software (Bruker Daltonics
Tof 1.6 m). With such settings, the instrument usually
provides mass accuracy of 40–80 ppm, mass resolving
power of 1500–2000 and sensitivity of 10–50 fmol in the
2–6 kDa mass ranges for oligonucleotides.
192 samples were genotyped for 5 SNPs in MTHFR gene
by RFMP method (Table 2). We successfully called 956
genotypes (99.6%) with an average SNR of 27 for allele-
specific signal to non-allele signal (see Figure 2 for repre-
sentative spectra). Failures were all related with desalting
Table 1: Primers used for RFMP genotyping assay
SNPs tested Variation Sequence of Primer (5'-3') Polarity
rs1801133 CT AGCACTTGAAGGAGAAGGTGTggatgTGCGGGAG Sense
GCCTCAAAGAAAAGCTGCGTGATG Antisnese
rs2066462 CT ACCCAGGCGTCCCCTACCCTGggatgGCTCTCAG Sense
GACGTACATCTTCCTCTCGGCGCT Antisnese
rs1994798 CT GTGAGGGCCTGCAGACCTTCCggatgTGCAAATA Sense
TTCTGCCCTCCCGCTCCCAAGAAC Antisnese
rs2066470 CT TTCGAGATGTTCCACCCCGGGggatgCTGGACCC Sense
CTCATCTTCTCCCGGAGTCTCTCA Antisnese
rs1801131 AC AGATGTGGGGGGAGGAGCTGAggatgCAGTGAAG Sense
GTAAAGAACAAAGACTTCAAAGAC Antisnese
A five-nucleotide sequence (ggatg) embedded in the forward primer to introduce a FokI site in amplicon is indicated by small letters.BMC Genomics 2008, 9:276 http://www.biomedcentral.com/1471-2164/9/276
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step of restriction enzyme reaction mixtures (0.2%) and
spectrum acquisition in MALDI-TOF MS (0.2%). DNA
purification, PCR, and restriction enzyme digestion were
without failures (Table 3). Accuracy was determined
through independent sequencing. Forward and reverse
Sanger sequencing were performed and conservative reads
were made manually with the identity of the forward and
reverse loci blinded at the time of sequence interpretation.
Accuracy of Sanger sequencing was measured by compar-
ing reads for which the sequence of both strands existed.
950 of 960 sequence pairs were identical, for an accuracy
of 98.9%. Thus the 950 agreeing sequencing pairs were
compared to the RFMP genotyping set, giving rise to a
concordance rate of 99.8% between both methods (Table
3). The five markers were also genotyped on the identical
set of 192 samples by the Snapshot primer extension
assay. The assay indicated a concordance rate of 99.5%
(945/950) with Sanger sequencing (Table 4). Both the
Snapshot and RFMP methods were found to be accurate,
robust and required little optimization. Compared for
ease of use and throughput considerations, the RFMP
assay required less labor for reaction preparations and
more advantageous in serial throughput capacity than the
Snapshot method (about 8-fold) (Table 4). Time spent on
target amplification and post-PCR reactions (single base
extension or restriction digestion) was similar, serial
Schematic summary of the RFMP genotyping strategy Figure 1
Schematic summary of the RFMP genotyping strategy. PCR was done with primers designed to introduce a typeIIS 
restriction endonuclease recognition sequence (FokI = BstF5I; GGATG) 9 bases ahead of the polymorphism site. The enzymatic 
cleavage of the products leads to excision of two oligonucleotide fragments (7 mer and 13 mer) containing the variation site, 
and then masses of the resulting oligonucleotide fragments were examined by MALDI-TOF MS. Cleavage sites of FokI and 
BstF5I, an isoschizomer for FokI, are indicated by filled and blank triangles, respectively, and restriction endonuclease recogni-
tion site and primers by shaded bar and shaded arrows, respectively. One-base gap replaced by the artificial sequences and 
potential SNP site are denoted by blank space and a bold italic letter, respectively.
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throughput was largely dependent on capillary electro-
phoresis or MS. RFMP produced 18,336 read-outs in a day
by automatic data acquisition mode in MS setting while
Snapshot called 2,256 genotypes. In terms of cost-effec-
tiveness, we estimated the direct cost per test (reagents and
consumables) of the RFMP assay to be about $2 per indi-
vidual SNP reaction including PCR, restriction digestion,
desalting and the running cost including amortization of
MS platform (Table 4). The capital equipment costs for
the Biflex IV in our laboratory that are estimated to be
$50,000 including annual amortization and maintenance
are similar to that of automatic sequencer with a 96-capil-
lary system. Though the cost of genotyping per reaction is
high dependent on the ability to multiplex reactions and
miniaturization of reaction scale, the RFMP assay was esti-
mated to be lower than the Snapshot assay in our hands
since slightly higher amortization of MALDI-TOF MS
compared to automatic sequencer is quickly offset by its
cheaper running cost.
The presence of metal cations produces salt adducts, lead-
ing to reduced resolving power and low sensitivity. Vari-
ous desalting procedures have been established for DNA
analyses by MALDI-TOF MS (18–20). We used C18
reverse phase micro-column chromatography as an effec-
tive and inexpensive means for desalting oligonucleotides
with since it was recyclable by repeated washing with iso-
propanol up to ten times without remarkable loss of effi-
ciency. We have used fructose as matrix additive for less
dependency of the quality of mass spectra on laser power
for better ion abundance without compromising mass
resolving power as previously described [21,22]. Further-
more, chip-based dispensing on hydrophilic anchors or
re-crystallization on matrix-prespotted anchorchip plates
allowed robust and controlled, high-density formation of
small single crystals.
Allele frequency determination and haplotype analysis
To test for a relationship between estimated frequencies in
pools and direct counts from individuals, ratios were cal-
culated using the mean peak areas generated from multi-
ple mass spectra and compared to the defined pooling
ratios. For the markers rs1801133 and rs2066462, we
tested if there was a linear relationship between estimated
and real allele frequencies. By analysis of artificial pools
representing one allele in the frequency range from 0.05
to 0.95 a linear relation of estimated allele frequencies to
the expected ratios was observed with the 13 mer frag-
ment (rs1801133: R2 = 0.984, slope = 1.033, p = 0.755;
rs2066462: R2 = 0.965, slope = 1.011, p = 0.650). Using
the pooling strategy a minor allele with a frequency as low
as 0.05 in the pool could be accurately detected for both
markers. We have not observed that the significant differ-
ence obtained in dynamic range depends on which spec-
Table 3: Performance metrics of RFMP genotyping assay
Measured parameter Result
Reactionsa 960
Call rate (%)b 956/960 (99.6)
Failures attributable to
DNA purification 0
PCR 0
Restriction digestion 0
Desalting 2
MALDI-TOF MS 2
Average SNRb 27
Repeatability (%)c 575/576 (99.8)
Concordance with Sanger Sequencing (%)d 948/950 (99.8)
a, total reactions involved determination of the 5 SNP markers in 
MTHFR gene in 192 subjects.
b, average of the ratio of maximum allele signal to maximum non-
allele signal of the 5 SNP markers.
c, assessment was based on a new bundle of reactions corresponding 
to triplicate analysis of 2 SNPs in 96 samples.
d, the comparison includes 4 reactions that failed in the first 
experimental set-up and were repeated for the attributable steps.
Table 2: Expected masses of oligonucleotides resulting from restriction enzyme cleavage of PCR products for scoring 5 SNPs in 
MTHFR gene by RFMP method
SNPs Variation Seuences of restriction fragmentsa Expected mass (Da)
7 mer 13 mer 7 mer 13 mer
rs1801133 C CGGGAGc ATCGgCTCCCGCA 2226.4 3975.6
T CGGGAGt ATCGaCTCCCGCA 2241.4 3959.6
rs2066462 C TCTCAGc GGGCgCTGAGAGC 2136.4 4120.6
T TCTCAGt GGGCaCTGAGAGC 2151.4 4104.6
rs1994798 C CAAATAc AGATgTATTTGCA 2153.4 4068.6
T CAAATAt AGATaTATTTGCA 2168.4 4052.6
rs2066470 C GGACCCc GCTCgGGGTCCAG 2146.4 4071.6
T GGACCCt GCTCaGGGTCCAG 2161.4 4055.6
rs1801131 A GTGAAGa ACTTtCTTCACTG 2249.4 3955.6
C GTGAAGc ACTTgCTTCACTG 2225.4 3980.6
a, the varied bases of the SNP position in oligonucleotide fragments were noted by small letters.BMC Genomics 2008, 9:276 http://www.biomedcentral.com/1471-2164/9/276
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tral band is chosen for quantitation between 2 restriction
fragments, 7 mer and 13 mer. The 7 mers showed a lower
limit of minor allele detection as low as 5%, and a
dynamic range of 0.05 to 0.95 with R2 equal to a mean of
0.912 for both markers. Considering that 13 mer fragment
has 4 additional bases adjacent to the polymorphism orig-
inated from target sequences while the 7 mer has only the
polymorphic base, the result suggest better reflection of
13 mer fragment on real abundance due to the advanced
target specificity.
Allele frequency estimation of five SNPs selected from
public databases was made in pools generated from the
Korean population (192 subjects), and compared with
results from individual genotyping. The minor allele fre-
quency by the annotation standards of dbSNP database
for the particular marker ranged from 0.093 to 0.872 (Fig.
3). The mean of the absolute differences between cor-
rected allele frequency estimates in corresponding pools
and the expected frequencies was 0.014 (range from 0.005
to 0.028). To investigate the influence of the pool size on
the accuracy and reproducibility of the approach we con-
structed three pools of different sizes from previously gen-
otyped individuals. Comparing the corrected pool
estimates allele frequencies deviated from real frequencies
(0.468 for rs1801133) by 0.015, 0.013, and 0.014 in the
pools of sizes 96, 144, and 192, respectively. The standard
deviations for the corrected pool estimates were 0.018,
0.015, and 0.012. The results suggest that accurate allele
frequencies can be determined independently from the
number of individuals in the DNA pools tested. The use of
MALDI-TOF to determine allele frequencies for pooled
samples inevitably lead to limitation in accuracy and sen-
sitivity, considering intrinsic nature of MALDI-TOF meas-
uring relative ion abundance, which is largely influenced
by unequal amplification and/or differential ionization
efficiency relying on genotype sequences [23,24]. At the
current level of precision, the greatest value of the pooling
approach is likely to be its suitability as an initial screen to
rapidly and cost-efficiently identify which SNPs should
undergo individual genotyping within the range of minor
allele frequency higher than 0.05 as well as the quantity of
DNA used overall. The method required 25 reactions (5
SNPs, and 5 PCR replicates) for initial association testing
in contrast to 960 reactions made necessary by individual-
sample genotyping for 192 subjects. A follow-up by indi-
vidual genotyping of selected SNPs showing evidence of
association has two major benefits. First, it allows confir-
mation of the pooled estimates of frequency, and second,
it permits the reconstruction of the haplotype showing
linkage disequilibrium with the disease.
Hyperhomocysteinemia is caused by low intake of folate
and other B vitamins and by genetic factors, including
polymorphisms of genes encoding enzymes involved in
homocysteine remethylation, such as MTHFR, methio-
nine synthase, methionine synthase reductase, and vari-
ants of cystathionine synthase, which catalyzes the
irreversible step of the transsulfuration pathway [25].
SNPs with documented metabolic and biological effects
include MTHFR C677T, which is a strong determinant of
plasma total homocysteine in individuals with impaired
folate status [26]. The polymorphic MTHFR  mutations
(C677T and A1298C) have been suggested as a cause of
cardiovascular disease, colorectal neoplasias, neural tube
defects, and pregnancy complications, especially in
homozygotes for C677T, but also in compound heterozy-
gotes for C677T/A1298C [27,28]. The distribution of
677T and 1298C are known to be worldwide, but those
frequencies in different populations vary extensively and
the ethnic impact on the association with the clinical phe-
notypes remains controversial [29].
For analysis of a possible linkage among C677T
(rs1801133), A1298C (rs1801131) and other polymor-
phisms (rs2066470, rs2066462, rs1994798), haplotypes
of the five variations in Korean population (N = 192) were
built by employing a computational method (EM algo-
rithm). The results showed that the population are com-
posed of 8 haplotypes, and haplotype M1 and M2 were
Table 4: Comparison of RFMP with Snapshot assays for SNP scoring
Snapshot RFMP
Assay chemistry Minisequencing Restriction endonuclease digestion
Analyte Primer extended product Enzyme-digested amplicon
(single strand-origin) (both strands-origin)
Assay platfom Automatic sequencer MALDI-TOF MS
Accuracya 99.5% 99.7%
Throughput/day 2,256b 18,336
Cost per reactionc US$2.50 US$2.00
a, Concordance with Sanger sequencing
b, With a 96-capillary system
c, The estimations include reagents and consumables for PCR and post PCR reactions, and the running cost and amortization of each detection 
platform except labor charge.BMC Genomics 2008, 9:276 http://www.biomedcentral.com/1471-2164/9/276
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the most prevalent, constituting 71.9% of the samples,
which are 677T (rare allele) or 677C (common allele)
with residual SNPs all common alleles (Table 5). Of inter-
est, there was a strong association between the 677T allele
in exon 4, 31T (common) in intron 6 (rs1994798) and
1298A (common allele) in exon 7. These data suggest that
the MTHFR 677T alteration has occurred once on the 31T-
1298A haplotype (93.7%) as previously described by
Rosenberg et al [27]. It is also noted that 677T allele prefer
common alleles in residual 4 loci as shown in haplotype
M1, M6, and M8 though M6 and M8 have deviations in
rs1994798 and rs2066462, respectivley, suggesting the
existence of MTHFR 677T alteration on a founder haplo-
type that may have had a selective advantage. The pres-
ence of a high prevalence of the specific haplotypes within
MTHFR gene suggests compounding effects of the SNPs in
occurrence of complex diseases and might be worth fur-
ther investigation for better predicting power in genotype-
phenotype association studies.
Conclusion
In conclusion, the RFMP assay for SNP scoring utilizing
mass difference of oligonucleotides requires the simple
steps of single PCR amplification and restriction enzyme
digestion, and is amenable to high-throughput system.
The assay represents an improvement over previous meth-
ods in reliance on the direct mass determination of PCR
products rather than on an indirect analysis, where a base-
extended or fluorescent report tag is interpreted, both
DNA strands being analyzed in parallel, and the ensured
specific target amplification simultaneously with mass
analysis, providing an additional level of assay precision.
Using RFMP assay, we demonstrated highly reliable geno-
typing of five SNP markers in MTHFR gene, known to be
Representative MALDI-TOF MS spectra in individual samples Figure 2
Representative MALDI-TOF MS spectra in individual samples. Genotyping results for SNPs rs1801133; masses for a 
pair of 7 mer and 13 mer for C and T alleles were 2226.4/3975.6 and 2241.4/3959.6, respectivley and rs1801131; masses for a 
pair of 7 mer and 13 mer for A and C alleles were 2249.4/3955.6 and 2225.4/3980, respectivley. X- and y- axes represent rela-
tive ion abundance and mass to charge ratio, respectively.
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associated with hyperhomocysteinemia and cardiovascu-
lar diseases, and also provided the potential for applica-
tion to determination of allele frequencies in DNA pools
as a means of efficiently screening SNPs and prioritizing
them for further study. Therefore, we believe that the sim-
plicity, accuracy and amenability to high-throughput
screening analysis make the RFMP assay suitable for large-
scale genotype association study and a routine genotyping
platform in clinical laboratories.
Methods
SNP markers and primer design
SNPs rs1801133, rs2066462, rs1994798, rs2066470, and
rs1801131 (see Table 1) were selected from the NCBI
dbSNP database [30] and their flanking sequences were
retrieved from the UCSC genome browser [31]. Primers
were designed using proprietary software (PickCamp
ver9, GeneMatrix) and synthesized by Bioneer Ltd. (Seoul,
Korea). PickCamp software beta-version is available as
Additional file 1 of this article.
PCR amplification
Informed consent was obtained form all subjects and
experimental protocol conformed to the ethical guide-
lines of the 1975 Declaration of Helsinki. 50 ng of the
genomic DNA was used for the PCR reaction. PCR was
performed in 18 μl reaction mixture containing 20 mM
Tris-HCl (pH 8.4), 50 mM KCl, 0.2 mM of each dNTP, 10
pmol of each primer, and 0.4 units of Platinum® Taq DNA
polymerase (Invitrogen, Carlsbad, CA). The amplification
conditions included initial denaturation at 94°C for 2
min, 10 cycles of denaturation at 94°C for 15 sec, anneal-
ing at 50°C for 15 sec and extension at 72°C for 30 sec,
followed by 35 cycles of denaturation at 94°C for 15 sec,
annealing at 55°C for 15 sec, and extension at 72°C for
30 sec. The respective sequences of forward and reverse
primers used in the PCR for each SNP site are summarized
in Table 1. Sequences underlined in each primer were
engineered to insert new FokI site in amplicon as shown in
Figure 1.
Restriction enzyme digestion, desalting and MALDI-TOF 
analysis
Restriction enzyme digestion of PCR products was per-
formed by mixing the PCR reaction mixture with 10 μl of
buffer containing 50 mM potassium acetate, 20 mM Tris-
acetate, 10 mM magnesium acetate, 1 mM dithiothreitol,
and 1 unit of each FokI and BstF5I at 37°C for 15 min. The
resulting digest was purified by vacuum filtration through
a 384-well sample preparation plate containing 5 mg of
polymeric sorbent (Waters, Milford, MA) per well using
Microlab 4200 robotic liquid handler (Hamilton, Reno,
NV). Each well was equilibrated with 90 μl of 1 M triethy-
lammoninumacetate (pH 7.6). Each cleavage reaction
mixture was added to 70 μl of 1 M TEAA, pH 7.6 and
loaded into a well. After rinsing 5 times with 85 μl of 0.1
M TEAA pH 7.0, the plate was reassembled on a vacuum
Table 5: Haplotype frequencies inferred from genotype results of 192 Korean subjects determined by RFMP assay
Haplotype rs2066470 CT 
(0.188)
rs1801133 CT 
(0.468)
rs2066462 CT 
(0.062)
rs1994798 CT 
(0.872)
rs1801131 AC 
(0.093)
Counts Frequency (%)
M 1 CTCTA 1 4 4 0 . 3 7 5
M2 C C C T A 132 0.344
M 3 CCCCC 4 8 0 . 1 2 5
M4 T C T C C 28 0.073
M5 T C T C C 14 0.036
M6 C T C C A 10 0.026
M7 C C T C C 4 0.010
M 8 CTTTA 4 0 . 0 1 0
Total 384 1.000
Allele frequency measurements on pools for different poly- morphisms Figure 3
Allele frequency measurements on pools for differ-
ent polymorphisms. Expected allele frequencies are 
obtained by individual genotyping. The frequencies calculated 
from pool data were corrected for unequal allelic represen-
tation using at least eight mass spectra of heterozygotes. The 
error bars represent the standard deviation.
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manifold and eluted with 60 μl of 60% aqueous isopropa-
nol into a collection plate, which was placed on a heating
block at 115°C for 90 min. The desalted reaction mixtures
were resuspended with matrix solution containing 50 mg/
ml 3-hydroxy picolinic acid, 0.05 M ammonium citrate, 5
mg/ml of fructose, and 30% acetonitrile, and were spotted
in 3 μl volumes on a polished anchorchip plate (Bruker
Daltonics, Billerica, MA) using Microlab 4200 robotics or
resuspended with distilled water and dotted in 2 μl to pre-
spotted anchorchip plate which had only matrix crystal-
lized in advance. Mass spectra were acquired on a linear
MALDI-TOF MS (Bruker Daltonics Biflex IV) workstation.
Spectra were acquired in a positive ion, delayed extraction
mode. Typically, time-of-flight data from 20 – 50 individ-
ual laser pulses were recorded and averaged on a transient
digitizer, after which the averaged spectra were automati-
cally converted to mass by data processing software
(Bruker Daltonics Genotools version 1.0).
DNA sequencing and Snapshot assay
The RFMP results were compared with the results from
either direct sequencing or the clonal sequencing assay.
When direct sequencing results were not decisive, we
cloned the PCR products into the pCR-Script Amp cloning
vector (Stratagene, La Jolla, CA), for sequence analysis of
each clone. Sequence analysis was performed by ABI
PRISM 310 Genetic Analyzer (Applied Biosystems, New
York, NY). The primers used for Snapshot assay were
designed and the primer extension reactions were carried
out with SnaPshot™ multiplex mix (Applied Biosystems)
according to manufacturer's recommendations. The reac-
tion mixtures were run on ABI3700 (Applied Biosystems)
using POP6 polymer and analyzed by Genescan program.
Determination of allele frequencies in DNA pools
The concentration of the DNAs used to construct pools
was measured using the Picogreen reagents and kits
(Molecular Probes, Eugene, OR). The DNAs were diluted
to a final concentration of 8 ng/μl and equal amounts of
DNA were mixed to form the pools. Range pools were
constructed by mixing appropriate volumes of homozy-
gote DNA. The concentrations ranged from 50–50% to
95-5%, with 5% increments. Allele frequencies were cal-
culated using peak areas generated from mass spectra. All
spectra were smoothed by applying a 21-point Savitzky-
Golay filter function (Bruker Daltonics XMASS) to mini-
mize noise errors. Peak areas were estimated using TOF
1.6 m taking into account baseline correction and the
noise level of the spectrum. To evaluate the reproducibil-
ity of the frequency estimates, assays were performed in 5
replicates for each pool and marker. In order to take une-
qual representation of both alleles in the mass spectrum
into account, at least five heterozygotes were genotyped
individually as recommended by Le Hellard et al [24]. The
mean of the ratios obtained from the peak areas was used
to correct the final allele frequency estimates [29].
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